15th Aug 2025 22:09
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:
----------
Genedrive PLC - Manchester-based point-of-care pharmacogenetic testing company - Reacts to recent share price fall which it believes are connected to postings on a share chat platform, noting apparent communications from a member of staff at NICE with a member of the public. The National Institute for Health and Care Excellence is an independent organisation that provides national guidance and advice to improve health and social care. Genedrive highlights that the apparent communication refers to services provided by NHS Genomic Services overseeing laboratory genomic testing and not point of care technologies. The funding position is being kept under active review as noted in the apparent communication. Further, whilst the company is aware of the completion of the NHSE CYP2C19 pilot assessing logistics of deploying as a service at scale via laboratory or point of care, and what, based on interim assessment it anticipates to be a positive outcome supporting the role and impact of rapid CYP2C19 genetic testing in stroke patients, it has not yet been made aware of a publication date by NHSE and cannot confirm the dates reportedly conveyed in the communication.
----------
Bezant Resources PLC - copper and gold exploration company with projects in Africa, South America and the Philippines - On Wednesday agrees to buy 90% shareholding in Namib Lead and Zinc Mining Ltd from CL US Minerals LLC. NLZM owns an ore processing plant which once modified it is proposed to be used to process copper-gold run of mine ore from Hope and Gorob which has been pre-concentrated on-site using dry ore sorting technology. Bezant will pay USD2.5 million on completion together with royalty payments based on processing plant throughput and copper and other ore sales. Discussions are advancing on multiple options available for the financing package to develop the Hope and Gorob Project. The discussions range between debt or equity or a combination thereof, prepaid finance is also being considered as an addition or substitute within the package.
----------
Oracle Power PLC - Western Australia and Pakistan-focused minerals and power projects - Raises GBP500,000 via placing at 0.014 pence per share. Proceeds will be primarily used to progress the development of projects in Australia, as well as advancing projects in Pakistan, and for general working capital purposes. CMC Markets UK PLC acts as the company's placing agent in respect of the placing. Chief Executive Naheed Memon says: "We are progressing very well with our projects in Australia and moving ahead with the development of our energy projects in Pakistan. We expect to provide further updates to the market in due course. This fundraise will provide us with additional funds to accelerate development activities."
----------
SkinBioTherapeutics PLC - life science firm focused on skin health - Expects to report weaker annual revenue than market forecasts, due to order timing. It expects revenue for the year to June 30 between GBP4.5 million and GBP4.8 million, jumping from GBP1.2 million a year prior. "Revenues were slightly lower than market expectations due to timing of orders for Dermatonics and BTS, much of which occurred just after the year end," it adds. Expects earnings before interest, tax, depreciation and amortisation loss between GBP200,000 to GBP400,000 narrowed from GBP2.2 million a year ago. Post year-end, says July was a strong month with significant orders and good trading across the board, especially for the BTS business.
----------
Sancus Lending Group Ltd - London-based alternative financial services provider - Says revenue increases 29% to GBP9.7 million in the six months to June from GBP7.5 million a year prior. During the period, writes new loan facilities of GBP78.6 million, an increase of 54% from GBP51.0 million last year. This reflects increased activity levels across the group with the UK and Irish businesses, in particular, delivering growth. At June 30, assets under management of GBP259 million had risen 8.8% from GBP238 million. Estimates pretax profit of GBP100,000, swung from a GBP600,000 loss a year ago, which reflects organic growth, disciplined credit management, stable credit quality and a gain arising from the repurchase of a portion of the group's ZDP shares. In addition, enters into agreements with Paragon Bank PLC for the provision of a GBP20 million committed funding facility. The facility has a 3-year term and will increase the group's capacity to grow its property backed lending book in England, Wales and Scotland.
----------
Calnex Solutions PLC - Linlithgow, Scotland-based Calnex produces equipment for the telecommunications and cloud computing industries - Anticipates performance in financial 2026 will be in line with market expectations. Updating on trading, Calnex says it sees growing traction in the cloud and defence markets, along with a strong customer base, which provides confidences. Telecoms market has remained stable throughout the first few months of FY26 and the board expects telecoms activity levels to remain largely the same for the remainder of the year. Calnex's long-term customer relationships and broad footprint in a range of end markets, such as cloud computing and defence, means it is not reliant on a recovery in the telecoms market to deliver growth, it notes.
----------
Tirupati Graphite PLC - London-based flake graphite producer, with projects in Madagascar and Mozambique - Says commissioning of the fourth primary concentrator unit at the BK6 mine site was successfully completed on July 31 and as at the end of July, the Vatomina operation had 4 working PCUs. Production for July was 221 million tonnes of sellable graphite. Notes July saw significant unseasonal rainfall resulting in a loss of 17 days of mining operations. Sellable production totals 2,285 million tonnes since restart of operations in February. Expects target of 1,000 million tonnes per month production to be achieved in October, and not July as hoped. "It is very disappointing that a combination of factors including adverse weather and equipment failures have resulted in the forecast production ramp-up being behind schedule. We have a comprehensive plan of remediation measures and capacity upgrades to be implemented over the coming months and therefore still expect to be able to achieve the previous production guidance of 1,500 MTs per month by December 2025. The lower production clearly impacts our cash flow. While there have been some partly offsetting cash savings, we are evaluating the options to secure additional funding," company says.
----------
OptiBiotix Health PLC - York, England-based life sciences business - Says a product containing its Slimbiome appetite reducing offering has been launched. It has been launched in Hydroxycut, a weight loss supplement in the US. "This news is significant for the company as it represents the inclusion of SlimBiome in the products of one of the USA's most popular weight management brands which has led to orders totalling just under five metric tonnes for SlimBiome in 2025. The board believes that the opportunity has potential for future development and will provide further updates in due course," it adds.
----------
By Jeremy Cutler, Alliance News reporter
Comments and questions to [email protected]
Copyright 2025 Alliance News Ltd. All Rights Reserved.
Related Shares:
GenedriveBezant ResOracle PowerSkinbiotherap.Sancus LendParagon GroupCalnex Solutio.Tirupati GraphiteOptiBiotix Health